If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
15,820.00    -1,060.00 (-6.28%)
Bid:
15,720.00
Ask:
15,860.00
Spread: 140.00 (0.891%)
Market Cap: £1.21b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

March 2025 Trading Update

19 Mar 2025 08:00

RNS Number : 2754B
Goodwin PLC
19 March 2025
Β 

GOODWIN PLC

MARCH 2025 TRADING UPDATE

Β 

We are pleased to report that as of the end of February, the Group's forward order book has reached a new record of Β£300 million. This milestone reflects the strength of our long-term established contracts and the robustness of our business activities. As a result, we remain on track to deliver second-half profits comparable to those of the first half of the year.

Β 

One of the recent contributors to this success has been Noreva, our specialised nozzle check valve company based in Germany. Noreva has secured the largest order in its history-a $15 million contract to supply valves for an LNG project. This contract, to be fulfilled over the next two years, positions us well to benefit from the expected release of further LNG projects, in light of the growing global demand for LNG.Β 

Β 

The vertical integration within our Group continues to provide a substantial competitive advantage. A significant proportion of the castings for Noreva's major order will be sourced from Goodwin Steel Castings (GSC), our own foundry. Even though we are now casting at a rate of 10 Self Shielded Boxes (SSBs) per month for the nuclear decommissioning market, as well as continuing to cast components for the military contracts that GSC has won, all with multi-year delivery profiles and high likelihood of repeat orders, the foundry still has capacity to take on additional contracts. This puts us in an excellent position to continue to contribute to national strategic defence procurements in both the UK and USA.

Β 

Looking ahead, the Mechanical Division is poised for further success. While the majority of orders received this year will start to deliver financial returns in the next fiscal year, we are confident that this momentum will continue to build. Our significant investment over the past decade has equipped the Mechanical Division with the necessary facilities, size, and capability to handle increasing workloads across all areas. Our investment into the Goodwin Engineering Training Centre has also supported this growth by successfully operating for over 13 years and training over 300 apprentices to date. It is these individuals who now form part of the Group's highly skilled workforce that is required to sustain our expansion.

Β 

Meanwhile, our Refractory Division continues to grow and perform well. The investment casting markets, particularly in the jewellery sectors are expanding at an impressive rate, exceeding 10% growth in certain regions. As a global market leader, we are benefiting directly from this trend, with our powder companies in China, India and Thailand achieving record in-month results compared to previous years.

Β 

Capital expenditure across the Group has decreased significantly as expected. The primary ongoing project, which is non customer funded, is the construction of a new 1,200 mΒ² building at Noreva. Over the next few months, once the equipment has been delivered and installed, this facility will house a CNC press operation converting Duvelco polyimide resin powder into precision pressed parts. With the reduced capital expenditure and our improved profitability, we have successfully reduced Group net debt by a further Β£10 million since the half-year mark.

Β 

Finally, with respect to dividend payments, we re-confirm that the second and final instalment of 66.5p per share for the year ending 30th April 2024, approved at our last Annual General Meeting on 2nd October 2024, will be paid on 11th April 2025 to shareholders registered on 21st March 2025.

Β 

The Board is delighted with the Group's performance and the strategic positioning we have achieved. With our record order book, expanding capabilities, and strong financial foundation, we are well-placed to sustain our success and drive further growth in profitability.

Β 

T.J.W. Goodwin

Chairman

Β 

END LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGRGDXLXBDGUC
Date   Source Headline
2nd Apr 20124:34 pmRNSDirector/PDMR Shareholding
9th Mar 201210:08 amRNSInterim Management Statement
6th Jan 20129:48 amRNSDirector/PDMR Shareholding
5th Jan 20129:52 amRNSDirector/PDMR Shareholding
22nd Dec 201111:37 amRNSDirector/PDMR Shareholding
21st Dec 20119:00 amRNSHalf Yearly Report
12th Oct 20113:01 pmRNSResult of Annual General Meeting
12th Sep 20119:16 amRNSInterim Management Statement
26th Aug 20115:42 pmRNSAnnual Financial Report
26th Aug 20119:00 amRNSPreliminary Results Year to 30th April 2011
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
3rd May 201111:42 amRNSDirectors' Shareholdings
31st Mar 20116:12 pmRNSDirector/PDMR Shareholding
18th Mar 201112:31 pmRNSInterim Management Statement - 3rd quarter
8th Feb 20112:50 pmRNSDirectors' Shareholdings
23rd Dec 201012:13 pmRNSPosting of Interim Report
21st Dec 20107:00 amRNSInterim Report
13th Dec 20109:09 amRNSDirectorate Change
19th Oct 20109:39 amRNSDirectors' Shareholdings
14th Oct 201011:24 amRNSResult of Annual General Meeting
10th Sep 20109:55 amRNSInterim Management Statement
26th Aug 201010:53 amRNSAnnual Financial Report
23rd Aug 20107:00 amRNSPreliminary Results
21st Jun 20104:24 pmRNSDirector/PDMR Shareholding
9th Jun 20104:54 pmRNSDirector/PDMR Shareholding
24th May 20104:35 pmRNSPrice Monitoring Extension
31st Mar 20103:55 pmRNSDirector/PDMR Shareholding
24th Mar 20102:22 pmRNSDirector/PDMR Shareholding
12th Mar 20104:36 pmRNSDirector/PDMR Shareholding
9th Mar 20107:00 amRNS3rd Quarter Interim Management Statement
5th Feb 20104:35 pmRNSPrice Monitoring Extension
3rd Feb 20104:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20104:35 pmRNSPrice Monitoring Extension
20th Jan 20105:00 pmRNSHolding(s) in Company
23rd Dec 20099:30 amRNSDoc re. Interim Report
21st Dec 200911:51 amRNSInterim Report 31st October 2009
19th Oct 20092:17 pmRNSDirectors' Shareholdings
14th Oct 20094:45 pmRNSResult of AGM
14th Oct 20094:40 pmRNSSecond Price Monitoring Extn
14th Oct 20094:35 pmRNSPrice Monitoring Extension
9th Oct 20093:59 pmRNSDirector's Shareholding
28th Sep 20099:20 amRNSDirector's Shareholding
9th Sep 20093:52 pmRNSInterim Management Statement
28th Aug 200912:27 pmRNSReport and Accounts year ended 30 April 2009
21st Aug 20099:30 amRNSFinal Results
16th Mar 200912:27 pmRNSInvestor Day
9th Mar 20092:36 pmRNSInterim Management Statement
16th Jan 20094:26 pmRNSDirector/PDMR Shareholding
23rd Dec 20084:41 pmRNSDoc re. Unaudited Interim Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.